Transparency data

Non-tech summaries 2016: projects on cardiovascular system

Projects granted during 2016 that have a primary purpose of basic research: cardiovascular, blood and lymphatic system.

• From: Home Office
• Published: 22 December 2017

Documents

Non-technical summaries: projects granted in 2016, volume 2

PDF, 339 KB, 49 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2016 with a primary purpose of basic research: cardiovascular, blood and lymphatic system.

The following projects were granted:

• cellular electrophysiology of cardiac arrhythmias (atrial fibrillation, atrioventricular node, ion channel, myocyte, ventricular tachyarrhythmia)

• cell mechanisms controlling small blood vessel diameter (arteries, vasodilatation, endothelium, smooth muscle)

• genetic and pharmacological analysis of thrombosis (bleeding, thrombosis, platelets)

• examining SLFN14 function in megakaryocytes and platelets (platelets, megakaryocytes, haemostasis, bleeding)

• genetic and environment effects on heart development (mouse embryo, development, heart, diabetes, hypoxia)

• image guided therapy for cardiovascular disease (imaging, heart, stroke, ischaemia, therapy)

• gene cell therapies for ischaemic disease (myocardial infarction, ischaemia, diabetes, stem cells)

• re-defining the roles of integrins in angiogenesis (angiogenesis, integrins, endothelium)

• platelet formation and function in thrombosis and repair (platelets, bleeding, thrombosis, regeneration, heart-attack)

• mechanisms of cardiovascular regeneration (regeneration, epicardium, neovascularisation, vascular protection)

• the regulation of platelet function as a central mechanism for the control of cardiovascular function and development (platelets, thrombosis, heart attack, stroke, clotting)

• zebrafish: development, physiology and disease modelling (zebrafish, development, physiology, disease, transgenic)

• regulation of leukocyte-endothelial interactions (inflamation, atherosclerosis, leukocytes)

• cardiac remodelling and heart failure (atrial fibrillation, heart failure, ion channel, myocyte, ventricular tachyarrhythmia)

• morphogenesis during early mammalian development (embryo, congenital defect, cell movement)

Published 22 December 2017